Stelara

With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US
Fierce Pharma
Thu, 02/29/24 - 06:57 pm
JNJ
Stelara
biosimilars
Biocon Biologics
J&J focuses on newer meds to offset Stelara patent cliff
BioPharma Dive
Wed, 01/24/24 - 10:52 am
JNJ
Stelara
patents
patent cliff
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Thu, 11/30/23 - 11:20 pm
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
Tue, 11/7/23 - 09:48 am
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Amgen scores FDA approval for Stelara biosimilar
Pharmaceutical Technology
Wed, 11/1/23 - 10:16 pm
Amgen
Stelara
biosimilars
JNJ
FDA
Wezlana
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
Mon, 10/16/23 - 11:50 am
AbbVie
Akyrizi
JNJ
Stelara
Crohn's Disease
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Thu, 10/12/23 - 10:22 am
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
JNJ
Stelara
patents
legal
Formycon
Fresenius Kabi
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Wed, 03/29/23 - 03:56 pm
Amgen
JNJ
Stelara
psoriasis
patents
biosimilars
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
JNJ
patents
Janssen
Amgen
biosimilars
Stelara
J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges
Endpoints
Tue, 01/24/23 - 06:36 pm
JNJ
revenue
earnings
Stelara
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
Endpoints
Tue, 08/2/22 - 12:03 am
JNJ
Stelara
pediatric
psoriatic arthritis
The patent winter is coming
EP Vantage
Wed, 05/25/22 - 10:41 am
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ

Pages